RevBio, Inc.
PrivateLast Round
Grant
Oct 6, 2023
Total Funding Raised
$14.8M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
RevBio, Inc. is a clinical-stage medical device company developing a patented, synthetic, injectable, and osteoconductive bone adhesive biomaterial called TETRANITE® for use in dental and orthopedic applications.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Clinical Trials, Advanced Materials
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
RevBio, Inc. Comparables
Compare RevBio, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Theradaptive | 84% | |
| OSSIO | 77% | |
| IlluminOss Medical | 77% |
RevBio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Oct 6, 2023 | ||||
| Grant | Sep 16, 2023 | ||||
| Grant | Jun 7, 2023 | ||||
| Strategic | Feb 14, 2023 | ||||
| Accelerator | Jun 7, 2022 | ||||
VC Round | Jun 11, 2021 |
Key People
Founding team and executive leadership
RevBio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| MedTech Innovator | Accelerator |
| NIH RADx | Grant |
| National Institute on Aging | Grant |
| MassChallenge Israel | Grant |
| National Institute of Dental and Craniofacial Research | Grant |
| National Institute of Neurological Disorders and Stroke | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 69% MoM.
- Jul 4, 2025
Monthly visitors increased 170% MoM, reaching 8.1K.
RevBio, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about RevBio, Inc.'s valuation, stock price, and market status.
Is RevBio, Inc. a public or private company?
RevBio, Inc. is a private company.
What is the current stock price of RevBio, Inc.?
RevBio, Inc. is a private company, so its shares have no public market price. Caplight tracks RevBio, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is RevBio, Inc. worth (valuation)?
Valuation information for RevBio, Inc. is not publicly available.
Can I buy RevBio, Inc. stock?
RevBio, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was RevBio, Inc.'s last funding round?
RevBio, Inc.'s most recent funding round was Grant on October 6, 2023.
Who are the main investors in RevBio, Inc.?
Key investors in RevBio, Inc. include MedTech Innovator, National Institute on Aging, National Institute of Dental and Craniofacial Research, National Institute of Neurological Disorders and Stroke.
Will RevBio, Inc. IPO soon?
No public IPO plans have been announced for RevBio, Inc..
How can I track RevBio, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in RevBio, Inc.'s shares on secondary markets.